Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 3Leukoplakia, Oral 2Insulin Resistance 2Diabetes Mellitus 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene 1Sleep Apnea, Obstructive 1Skin Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Metabolic Syndrome 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Head and Neck Neoplasms 1Glucose Intolerance 1Diabetes Mellitus, Type 2 1Carotid Intimal Medial Thickness 1 1Carcinoma, Squamous Cell 1

Interventions

relacorilant 3empagliflozin 1Resistance Training 1Pioglitazone 1Metformin 1Exercise 1Dipeptidyl-Peptidase IV Inhibitors 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Diabetes Mellitus, Type 2 × Pioglitazone × Clear all
NCT01223196 2016-01-11

PIO-TACE

The University of Texas Health Science Center at San Antonio

Phase 4 Completed
60 enrolled 8 charts

Diabetes Mellitus, Type 2, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡